Skip to Main Content

Author Details

Lynda A Szczech
FibroGen Inc.
1997
173
54
PMIDPaper TitleJournal TitlePublished Year
35257087Retraction notice to "Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis." <i>Kidney Int Rep</i>. 2021;6:613-623.Kidney Int Rep2022
36245647Changes in Iron Availability with Roxadustat in Nondialysis- and Dialysis-Dependent Patients with Anemia of CKD.Kidney3602022
34307977A Randomized Trial of Roxadustat in Anemia of Kidney Failure: SIERRAS Study.Kidney Int Rep2021
33629100Roxadustat for anemia in patients with end-stage renal disease incident to dialysis.Nephrol Dial Transplant2021
34362786Efficacy and Cardiovascular Safety of Roxadustat for Treatment of Anemia in Patients with Non-Dialysis-Dependent CKD: Pooled Results of Three Randomized Clinical Trials.Clin J Am Soc Nephrol2021
33732976Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis.Kidney Int Rep2020
33732977Roxadustat for CKD-related Anemia in Non-dialysis Patients.Kidney Int Rep2020
30971708An Equation Based on Fuzzy Mathematics to Assess the Timing of Haemodialysis Initiation.Sci Rep2019
31501092Assessment of dialysis initiation by a fuzzy mathematics equation (ADIFE): a study protocol for a randomised controlled trial.BMJ Open2019
31340116Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis.N Engl J Med2019
31340089Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis.N Engl J Med2019
27699882What are the Considerations in Balancing Benefits and Risks in Iron Treatment?: How Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitors May Change Iron Management in End-Stage Renal Disease.Semin Dial2017
28371815Phase 2 studies of oral hypoxia-inducible factor prolyl hydroxylase inhibitor FG-4592 for treatment of anemia in China.Nephrol Dial Transplant2017
26846333Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6- to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study.Am J Kidney Dis2016
27094610Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD.Clin J Am Soc Nephrol2016
24980979Uses and interpretation of iron studies in patients on chronic dialysis.Semin Dial2014
25419504Investigators' Experience With Expedited Safety Reports Prior to the FDA's Final IND Safety Reporting Rule.Ther Innov Regul Sci2014
25427285Primary care detection of chronic kidney disease in adults with type-2 diabetes: the ADD-CKD Study (awareness, detection and drug therapy in type 2 diabetes and chronic kidney disease).PLoS One2014
23254151Tenofovir use and urinary biomarkers among HIV-infected women in the Women's Interagency HIV Study (WIHS).J Acquir Immune Defic Syndr2013
23891356KDOQI US commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD.Am J Kidney Dis2013
23855141ESA dose vs. Hb levels: what needs to be monitored?Nephrol News Issues2013
23735819Cardiovascular toxicity of epoetin-alfa in patients with chronic kidney disease.Am J Nephrol2013
23523238Patient and caregiver knowledge and utilization of partial versus radical nephrectomy: results of a national kidney foundation survey to assess educational needs of kidney cancer patients and caregivers.Am J Kidney Dis2013
22333744Atrial fibrillation: the beat is faster than the answers.Kidney Int2012
23067630A decade after the KDOQI CKD guidelines: impact on the National Kidney Foundation.Am J Kidney Dis2012
22713094Restless legs syndrome reported by incident haemodialysis patients: is treatment time of day relevant?Nephrology (Carlton)2012
22537421Effect of hemoglobin target on progression of kidney disease: a secondary analysis of the CHOIR (Correction of Hemoglobin and Outcomes in Renal Insufficiency) trial.Am J Kidney Dis2012
22573238Impact of higher hemoglobin targets on blood pressure and clinical outcomes: a secondary analysis of CHOIR.Nephrol Dial Transplant2012
21191387Getting the urine to the lab: time to think outside of the specimen cup.Kidney Int2011
22053343Association of race and age with survival among patients undergoing dialysis: racial differences on many levels.Kidney Int2011
22152013Association between high-dose erythropoiesis-stimulating agents, inflammatory biomarkers, and soluble erythropoietin receptors.BMC Nephrol2011
21913987Veterans more likely to start hemodialysis with an arteriovenous fistula.Semin Dial2011
21610681Chronic kidney disease: Association between ESA use and stroke in patients with CKD.Nat Rev Nephrol2011
21464937Prevalence of kidney disease in HIV-infected and uninfected Rwandan women.PLoS One2011
21508633Reduced kidney function and preclinical atherosclerosis in HIV-infected individuals: the study of fat redistribution and metabolic change in HIV infection (FRAM).Am J Nephrol2011
21421134Where is Walter--if he isn't in my office, is he really my responsibility? The 2011 National Kidney Foundation Presidential Address.Am J Kidney Dis2011
21228588Chronic kidney disease anemia management: what should be done?Blood Purif2011
20103500Perioperative outcomes among patients with end-stage renal disease following coronary artery bypass surgery in the USA.Nephrol Dial Transplant2010
21083392Tackling the unknowns in HIV-related kidney diseases.N Engl J Med2010
20734474Journal club. Cystatin C and contrast-induced acute kidney injury.Kidney Int2010
20709438Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons.Am J Kidney Dis2010
20458014Acute kidney injury and cardiovascular outcomes in acute severe hypertension.Circulation2010
20466657Randomized evaluation of efficacy and safety of ferric carboxymaltose in patients with iron deficiency anaemia and impaired renal function (REPAIR-IDA): rationale and study design.Nephrol Dial Transplant2010
20611034Hemodialysis does not significantly affect the pharmacokinetics of nevirapine in HIV-1-infected persons requiring hemodialysis: results from ACTG A5177.J Acquir Immune Defic Syndr2010
20631675Hypothesis: an erythropoietin honeymoon phase exists.Kidney Int2010
20581688The impact of kidney function at highly active antiretroviral therapy initiation on mortality in HIV-infected women.J Acquir Immune Defic Syndr2010
20186158Anemia trials: lessons for clinicians, politicians, and third-party payers.Kidney Int2010
19890274A secondary analysis of the CHOIR trial shows that comorbid conditions differentially affect outcomes during anemia treatment.Kidney Int2010
20005494Management of HIV-infected patients with ESRD.Adv Chronic Kidney Dis2010
20005483HIV through a nephrologist's lens.Adv Chronic Kidney Dis2010
  • 1 - 50 of 173

Recommended Authors

Icahn School of Medicine at Mount Sinai
Career Start Year 2014
Number of shared co-authors 1
University of Florida-School of Medicine
Career Start Year 2012
Number of shared co-authors 0
Selzman Institute for Kidney Health, Baylor College of Medicine
Career Start Year 2012
Number of shared co-authors 1
Stony Brook University Hospital
Career Start Year 2011
Number of shared co-authors 0
Icahn School of Medicine at Mount Sinai
Career Start Year 2010
Number of shared co-authors 7
University of Utah Health
Career Start Year 2005
Number of shared co-authors 0
Selzman Institute for Kidney Health, Baylor College of Medicine
Career Start Year 2004
Number of shared co-authors 3
The George Institute for Global Health
Career Start Year 2004
Number of shared co-authors 2
Kidney Research Institute, University of Washington
Career Start Year 2003
Number of shared co-authors 3
Nashville VA Medical Center, VA Tennessee Valley Healthcare System
Career Start Year 2002
Number of shared co-authors 3
DaVita Clinical Research
Career Start Year 2002
Number of shared co-authors 2
Western University
Career Start Year 2001
Number of shared co-authors 6
University of North Carolina at Chapel Hill
Career Start Year 2000
Number of shared co-authors 2
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 0
Montefiore Medical Center and Albert Einstein College of Medicine
Career Start Year 1999
Number of shared co-authors 1
LSU Health New Orleans School of Medicine
Career Start Year 1999
Number of shared co-authors 0
Tufts Medical Center
Career Start Year 1998
Number of shared co-authors 3
Washington University in St. Louis.
Career Start Year 1998
Number of shared co-authors 1
New York University Grossman School of Medicine
Career Start Year 1996
Number of shared co-authors 5
University of Toronto
Career Start Year 1996
Number of shared co-authors 6
Boston University Chobanian & Avedisian School of Medicine, Boston Medical Center
Career Start Year 1995
Number of shared co-authors 5
Vanderbilt University Medical Center
Career Start Year 1994
Number of shared co-authors 4
The Lilibeth Caberto Kidney Clinical Research Unit, Western University
Career Start Year 1993
Number of shared co-authors 3
University of California San Diego
Career Start Year 1989
Number of shared co-authors 1
Vanderbilt University Medical Center
Career Start Year 1988
Number of shared co-authors 0
University of Virginia Health
Career Start Year 1987
Number of shared co-authors 5
Christiana Care Health Services Inc.
Career Start Year 1987
Number of shared co-authors 2
University of Pittsburgh School of Medicine
Career Start Year 1984
Number of shared co-authors 5
Baystate Medical Center-University of Massachusetts Springfield
Career Start Year 1982
Number of shared co-authors 2
Mayo Clinic
Career Start Year 1978
Number of shared co-authors 0

Collaborators

Co-authored papers 23
Duke University
Co-authored papers 16
From the National Institutes of Health
Co-authored papers 14
Kidney Research Institute and Division of Nephrology, University of Washington
Co-authored papers 10
Co-authored papers 8
University of North Carolina
Co-authored papers 6
University of California san francisco
Co-authored papers 5
Co-authored papers 5
Truth for Health Foundation
Co-authored papers 4
Rutgers University School of Public Health
Co-authored papers 4
Co-authored papers 4
University of Texas Southwestern Medical Center
Co-authored papers 4
Duke University School of Medicine
Co-authored papers 4
Duke University Medical Center-Duke Clinical Research Institute
Co-authored papers 4
University of North Carolina at Chapel Hill
Co-authored papers 4
Universidade Federal de Sao Paulo
Co-authored papers 3
University of Cincinnati College of Medicine President
Co-authored papers 3
Duke University School of Medicine
Co-authored papers 3
Duke Clinical Research Institute, Duke University
Co-authored papers 3
Co-authored papers 3
Duke University
Co-authored papers 2
Co-authored papers 2
College of Veterinary Medicine, Shanxi Agricultural University
Co-authored papers 2
University of California San Francisco
Co-authored papers 2
Duke Clinical Research Institute
Co-authored papers 2
Shanghai Institute of Kidney and Dialysis
Co-authored papers 2
Duke University School of Medicine
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Mayo Clinic
Co-authored papers 1